~~<i id='F8D800AE09'><strike id='F8D800AE09'><tt id='F8D800AE09'><pre id='F8D800AE09'></pre></tt></strike></i>~~

Home» comprehensive» fashion

fashion

author：leisure time 2025-09-30 02:27:30 Page View：95

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Federal judge rules Oregon’s tough new gun law is constitutional
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

Congress likely to miss an opportunity to fix drug shortages issue

LeeKlafczynskiforSTATWASHINGTON—Congressisconsideringamust-passpandemicpreparednessbillthatpresentsa

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

As the dark side of IVF slowly comes into focus, even more transparency is needed

AselectionofIVFhormonebottlesandsyringesattheScienceMuseuminLondon,England.LeonNeal/GettyImagesIwas1